Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease
- Conditions
- Interventions
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2021-08-16
- Lead Sponsor
- Allergan
- Target Recruit Count
- 14
- Registration Number
- NCT03827564
- Locations
- 🇺🇸
Baylor College of Medicine - Department of Ophthalmology, Houston, Texas, United States
Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia
- Conditions
- Interventions
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2021-12-28
- Lead Sponsor
- Allergan
- Target Recruit Count
- 323
- Registration Number
- NCT03804268
- Locations
- 🇺🇸
American Institute of Research, Los Angeles, California, United States
🇺🇸Eye Research Foundation, Newport Beach, California, United States
🇺🇸Danbury Eye Physicians and Surgeons P.C., Danbury, Connecticut, United States
A Study to Evaluate the Effectiveness of Juvéderm® VOLIFT™ With Lidocaine for Lip Augmentation
- First Posted Date
- 2019-01-08
- Last Posted Date
- 2021-07-28
- Lead Sponsor
- Allergan
- Target Recruit Count
- 60
- Registration Number
- NCT03796728
- Locations
- 🇵🇹
Clinica Milenio, Lisbon, Portugal
🇵🇹Clínica Secret Beauty, Lisbon, Portugal
🇬🇧Medical and Cosmetic Clinic, Edinburgh, United Kingdom
Diabetic Gastroparesis Study 05
- First Posted Date
- 2018-12-26
- Last Posted Date
- 2021-12-15
- Lead Sponsor
- Allergan
- Target Recruit Count
- 202
- Registration Number
- NCT03786380
- Locations
- 🇺🇸
Rocky Mountain Diabetes and Osteoporosis Center, PA, Idaho Falls, Idaho, United States
🇺🇸University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Preferred Primary Care Physicians, Inc., Pittsburgh, Pennsylvania, United States
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
- First Posted Date
- 2018-12-17
- Last Posted Date
- 2021-07-09
- Lead Sponsor
- Allergan
- Target Recruit Count
- 910
- Registration Number
- NCT03777059
- Locations
- 🇺🇸
Advanced Research Associates, Glendale, Arizona, United States
🇺🇸Orange Grove Family Practice, Tucson, Arizona, United States
🇺🇸Principals Research Group, Hot Springs, Arkansas, United States
Dynamic Optical Coherence Tomography(D-OCT) Aging Study: A Preliminary Evaluation of Structural Differences Between Young and Aged Skin, Cellulite and Atrophic Acne Scars in Female Caucasian Subjects With Fitzpatrick Skin Types I-III Utilizing Non-invasive in Vivo D-OCT.
- First Posted Date
- 2018-12-06
- Last Posted Date
- 2019-10-31
- Lead Sponsor
- Allergan
- Target Recruit Count
- 99
- Registration Number
- NCT03767400
- Locations
- 🇺🇸
Skinmedica Clinical Research and Innovation Center, Irvine, California, United States
JUVÉDERM® VOLITE™ XC for Cheek Skin Smoothness
- Conditions
- Interventions
- First Posted Date
- 2018-11-02
- Last Posted Date
- 2022-12-19
- Lead Sponsor
- Allergan
- Target Recruit Count
- 209
- Registration Number
- NCT03728309
- Locations
- 🇺🇸
Ava MD, Santa Monica, California, United States
🇺🇸Facial Plastic Surgery Center /ID# 234876, Baltimore, Maryland, United States
🇺🇸Dallas Center for Dermatology and Aesthetics /ID# 234452, Dallas, Texas, United States
Study of the Safety and Effectiveness of JUVÉDERM VOLUX™ XC Injectable Gel for Restoring Jawline Definition
- Conditions
- Interventions
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Allergan
- Target Recruit Count
- 206
- Registration Number
- NCT03712137
- Locations
- 🇺🇸
Center aesthetic and dermatology, New York, New York, United States
🇺🇸Total Skin and Beauty Dermatology Center, PC, Birmingham, Alabama, United States
🇺🇸DeNova Research dba Arano, LLC, Chicago, Illinois, United States
A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial Treatment
- Conditions
- Interventions
- First Posted Date
- 2018-10-19
- Last Posted Date
- 2023-10-31
- Lead Sponsor
- Allergan
- Target Recruit Count
- 59
- Registration Number
- NCT03712449
- Locations
- 🇨🇦
Project Skin MD Vancouver, Vancouver, British Columbia, Canada
🇨🇦Pacific Derm, Vancouver, British Columbia, Canada
🇨🇦Carruthers & Humphrey Cosmetic Dermatology, Vancouver, British Columbia, Canada
Study to Evaluate the Safety and Tolerability of Treatment With Atogepant 60 mg Daily for the Prevention of Migraine in Participants With Episodic Migraine
- Conditions
- Interventions
- First Posted Date
- 2018-10-09
- Last Posted Date
- 2021-06-15
- Lead Sponsor
- Allergan
- Target Recruit Count
- 744
- Registration Number
- NCT03700320
- Locations
- 🇺🇸
iResearch Atlanta, Decatur, Georgia, United States
🇺🇸FutureSearch Trials of Dallas, LP, Dallas, Texas, United States
🇺🇸Rapid Medical Research, Inc., Cleveland, Ohio, United States